Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
Abbott, absence, absolute, ABSTAINING, accidental, Actelion, advantage, affordable, Alzheimer, American, analyzing, anxiety, Appendix, Aptuit, Arab, Arena, armed, ascending, ascribed, asset, assist, attempting, Australia, Aviv, awaiting, bankruptcy, baseline, bioequivalent, bridge, budget, Cambridge, Canada, capacity, carcinogenicity, cell, cellular, certainty, Certified, certify, CFFT, channel, chemistry, chronic, cognitive, commonly, conflict, construction, consumation, consuming, contamination, context, COPD, correct, CoTherix, currency, curtail, Cystic, deal, deficient, delivery, denial, depression, depressive, developmental, die, disagreement, disclaim, discounted, discretion, disorder, disrupted, disruption, dosage, drop, duty, elderly, Electronic, Eli, embedded, embodied, Encysive, endpoint, enterprise, environmental, Ernst, estate, exhibit, exhibited, experimental, external, extraordinary, fact, FAS, fewer, Forest, formulate, formulation, Foundation, framework, fraud, GAD, Gan, Germany, GlaxoSmithKline, goodwill, gradually, Guide, Hamilton, harbor, headquarter, heavily, highly, hostility, hypertension, Iceland, import, important, imposition, inactivation, incentive, incidence, inconclusive, inconsistent, increasingly, indeterminate, inin, injury, instability, instance, insufficient, intangible, intercompany, intervention, Israel, Israeli, Johnson, large, Leader, Lexington, ligand, likelihood, Lilly, LLP, MA, Matthey, mechanism, mediating, Medicare, MediciNova, membrane, merged, met, military, mimic, modulate, monetary, moved, moving, Myogen, Myriad, necessitate, Neurochem, newly, NJ, noncancellable, nonmonetary, nonrefundable, Norway, obesity, obstructive, occurrence, onForm, ordinary, organization, ostensibly, ourin, outweigh, overhead, oversee, packaging, paragraph, partial, partially, Perez, performin, permanently, Pfizer, Pharma, Physiome, pivotal, placebo, platform, play, political, pollution, poor, post, potent, predecessor, prescription, pressure, Princeton, processed, publicly, pulmonary, purport, put, quantifiable, Ramat, Ramot, rapidly, ratify, real, reclassified, reclassifying, recover, release, reliably, remeasured, rent, reproducible, reserve, Roche, safer, safest, schizophrenia, secondary, serotonergic, serotonin, settlement, Shacham, Sharon, shut, silico, silicotechnology, slowly, subsection, subset, substance, subtle, successor, surface, suspension, Switzerland, synthesizing, Tel, temporarily, terrorist, thein, thereunder, tort, traditional, unexpected, unfavorably, unformulated, University, updated, urge, viability, viable, violence, vivofunctional, war, wholly, write, written, Wyeth, Young
Removed:
APB, appoint, assessment, assuming, Astrue, attaining, blinded, capable, carried, choose, cleanup, collection, collectively, compromising, confirmation, consolidate, continual, counsel, credit, Daiichi, detecting, detection, discontinuance, drafting, eligible, enhanced, environment, Error, establish, execute, expenditure, exposed, finance, gaining, good, granting, guarantee, III, inclined, IND, indefinitely, initially, innovative, invasive, investigational, joint, lab, legislative, length, manufactured, member, modify, monitored, MRA, outlay, outsource, ownership, pedal, periodic, plaintiff, proceed, reading, redeemed, refer, reform, regulated, reimburse, replacement, respond, rollover, scheduled, taxable, thrombi, type, unearned, utilization, vasovisttm, Webb, widely, world
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 3.1 EX-3.1 Restated Certificate of Incorporation
- 4.1 EX-4.1 Specimen Certificate for Shares of Common Stock
- 4.3 EX-4.3 Warrant Issued to RRD International, LLC
- 4.4 EX-4.4 Warrant Issued to General Electric Capital Corporation
- 4.5 EX-4.5 Warrant Issued to Oxford Bioscience Management Partners II
- 10.1 EX-10.1 Predix Pharmaceuticals Holdings, Inc. Amended and Restated 2003 Stock Incentive Plan
- 10.2 EX-10.2 Physiome Sciences, Inc. 1997 Stock Option Plan
- 10.3 EX-10.3 Amended and Restated License Agreement
- 10.4 EX-10.4 Research Development and Commercialization Agreement
- 10.5 EX-10.5 License Agreement by and Between Predix Pharmaceuticals Holdings, Inc. and Amgen Inc.
- 10.6 EX-10.6 Lease by and Between Trustees of 4 Maguire Road Realty Trust and the Predix Pharmaceuticals Holdings, Inc.
- 10.7 EX-10.7 Lease Agreement
- 10.8 EX-10.8 Sublease Agreement
- 10.9 EX-10.9 Unprotected Lease Agreement
- 10.10 EX-10.10 Employment Agreement, Michael G. Kauffman, M.D., PH.D.
- 10.11 EX-10.11 Employment Agreement, Silvia Noiman, PH.D.
- 10.12 EX-10.12 Employment Agreement, Kimberlee C. Drapkin
- 10.13 EX-10.13 Employment Agreement, Chen Schor
- 10.14 EX-10.14 Employment Agreement, Oren Becker, PH.D.
- 10.15 EX-10.15 Employment Agreement, Stephen R. Donahue, M.D.
- 31.1 EX-31.1 Section 302 Certification of CEO
- 31.2 EX-31.2 Section 302 Certification of CFO
- 32.1 EX-32.1 Section 906 Certification of CEO & CFO
Related press release
EPIXE similar filings
External links